- Compose a motivational email to internal staff that discusses two advantages and two disadvantages of the product and explain how to mitigate the disadvantages should they occur.
- Compose an informational email to external stakeholders (i.e., investors, shareholders) that discusses two distinct organizational and/or financial impacts the product will create.
- Compose a consumer-facing blog post that highlights three distinct benefits of the product and informs the consumers what sets this product and/or business apart from others in the industry.
- Compose a persuasive letter to the business partner to discuss their challenges in meeting your production needs.
- Compose responses to the customer complaint about the product that was posted on the company’s social media page by doing the following:
- Develop a public response that acknowledges the customer complaint and improves the company image within the social media page.
- Develop a direct private message with a proposed adjustment (resolution) for the customer.
- Evaluate the communication strategies and methods (i.e., email, letter, blog, and social media) used in items A–E by doing the following:
- Explain how the communication strategies support or do not support the desired outcomes and provide examples to support your conclusion.
- Explain how the four communication methods effectively or ineffectively serve the target audience and provide examples to support your conclusion.
- Acknowledge sources, using APA-formatted in-text citations and references, for content that is quoted, paraphrased, or summarized.
- Demonstrate professional communication in the content and presentation of your submission.
The scenario is
You are a manager in a small pharmaceutical distributor. Your company has been awarded the exclusive contract to distribute a new medication.
Nasaquil is an over-the-counter medication that has been approved to treat influenza. Nasaquil will compete directly with prescription antiviral medications.
Your company, through your sales and customer service representatives, already has extensive relationships with medical providers. There is great anticipation within the market about the potential efficacy of this new medication. According to estimates by the Centers for Disease Control and Prevention (CDC), from October 1, 2018, to February 16, 2019, there were approximately 19 million flu illnesses in the United States with about 8–9 million flu-related medical visits (Centers for Disease Control and Prevention, 2019). Initial clinical trials indicate this new Nasaquil medication may help to lower influenza’s severity and duration; however, clinical trials only demonstrate a new medication’s efficacy in a small group of patients over a limited amount of time. Long-term product efficacy rates have not yet been established. As with all new medication launches, your company anticipates patient dissatisfaction if desired results are not achieved. In those cases, the company will work directly with the patient.
The success of Nasaquil relies upon an external business partner, Pruhart Tech, who manufactures the refrigerated casing designed specifically for this product. The product is required to be shipped overnight in a temperature-controlled package. Unfortunately, Pruhart Tech has limited refrigerated shipping containers, and the availability is restricted to weekend deliveries only. You will need to work closely with this partner to ensure their manufacturing operation is able to increase as needed in a just-in-time environment to meet sales demands. Your contact’s name at Pruhart Tech is Diego Garcia.
You have received a customer complaint via the company’s social media page. The customer is extremely dissatisfied, and the complaint has negatively impacted the company’s image. The customer’s complaint is as follows: “@Nasaquil does not work! My wife started Nasaquil and got very ill! I don’t understand how big pharma companies get away with rolling out unsafe drugs that can hurt people! Dealing with all of the medical appointments and issues is bad enough, but this sickness . . . I cannot wait for the patient support meeting tomorrow to share this medication’s reaction. Maybe this drug shouldn’t be approved yet.”